M A K E
H
I T
A
P
P
E
Codexis® continues to expand the frontiers of the possible in bio-basec science.
Take the recently completed collaborative research program we undertook in partnership with DSM on 7-ADCA. The challenge was to improve two enzymes suspected of limiting flux during fermentative production. Using our proprietary MolecularBreeding™ technologies we
Λ ' Ι β Ι β Û« f« it If»
were able to separately improve the activities of these enzymes in an in vivo system. This enzymatic 7-ADCA process has been scaled up and ls n o w
•"Ί»7'-ΑΓ)ΟΑ
^ein9
usecl t0
manufacture
product at commercial scale.
This is just one of the many challenging process improvements where our truly revolutionary technology is delivering for our life science partners.
,.«pe
Λ Η
"7 Û f^fs
£
M y° u
w a n t creat
* v e * innovative
bio-based solutions for your pharmaceutical» make it happen with Codexis.
V i s i t us o n 1879 H a l l 8 C P h l
CODEXIS
w w w . c o d e x i s . c o m
Call: US West Coast : 6$0*298~S328 US East Coast : 610-648*3905 Europe ; +44(0) 1865 823182
